With CAR-Ts approved in both the US and the EU, the advanced therapies field is answering the scientific questions of efficacy and safety – cell and gene therapies are becoming therapeutic realities. But new challenges are emerging...
How can manufacturing become more closed and automated to reduce the risks associated with human intervention and manual operations? How does the field overcome the problem of handling living breathing cells in transit? And are healthcare systems ready for cell and gene therapies?
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
